Radiotherapy in Uveal Melanoma: A Review of Ocular Complications

Curr Oncol. 2023 Jul 3;30(7):6374-6396. doi: 10.3390/curroncol30070470.

Abstract

Uveal melanoma represents the most prevalent form of primary malignant intraocular tumor in adults. Historically, enucleation was considered the gold-standard approach in the treatment of uveal melanoma. Currently, radiotherapy is the most commonly used therapy, aiming at a better quality of life. However, radiotherapy can result in several ocular complications, some of which may be vision-threatening. Radiation-induced dry eye, scleral necrosis, cataract, rubeosis iridis, neovascular glaucoma, radiation retinopathy, maculopathy, and optic neuropathy are the most common complications. This article aims to summarize the current literature regarding the ocular complications after radiotherapy, as well as their clinical features, risk factors, and management strategies. A thorough understanding of these issues is crucial for ophthalmologists and oncologists to provide optimal patient care, improve visual outcomes, and minimize long-term complications.

Keywords: ocular complications; radiotherapy; uveal melanoma.

Publication types

  • Review

MeSH terms

  • Adult
  • Humans
  • Melanoma* / radiotherapy
  • Quality of Life
  • Risk Factors
  • Uveal Neoplasms* / radiotherapy

Supplementary concepts

  • Uveal melanoma

Grants and funding

This research received no external funding.